Mis R - Search Results

1

A phase I clinical and pharmacokinetic study (LIPOTEC - GP PHARM/DOXO 01) of a new liposomal doxorubicin given as 3-week schedule in patients with solid tumors.

Majem M, Salazar R, Garcia M, Clopes A, Muñoz C, Pardo B, Martinez M, Cuadra C, Montes A, Mis R, Savulsky C, Ramon Germa-Lluch J. Majem M, et al. Among authors: mis r. J Liposome Res. 2009;19(4):261-6. doi: 10.3109/08982100902804833. J Liposome Res. 2009. PMID: 19863161 Clinical Trial.

2

Effectiveness, pharmacokinetics, and safety of a new sustained-release leuprolide acetate 3.75-mg depot formulation for testosterone suppression in patients with prostate cancer: a Phase III, open-label, international multicenter study.

Marberger M, Kaisary AV, Shore ND, Karlin GS, Savulsky C, Mis R, Leuratti C, Germa JR. Marberger M, et al. Among authors: mis r. Clin Ther. 2010 Apr;32(4):744-57. doi: 10.1016/j.clinthera.2010.04.013. Clin Ther. 2010. PMID: 20435244 Clinical Trial.

3

The pharmacokinetics and pharmacodynamics of a new sustained-release leuprolide acetate depot compared to market references.

Leitner JM, Mayr FB, Spiel AO, Firbas C, Savulsky C, Mis R, Corrado ME, Jilma B. Leitner JM, et al. Among authors: mis r. Int J Clin Pharmacol Ther. 2008 Aug;46(8):407-14. doi: 10.5414/cpp46407. Int J Clin Pharmacol Ther. 2008. PMID: 18793582 Clinical Trial.

4

Pharmacokinetics of fosfosal after single and multiple oral doses in man.

Ramis J, Torrent J, Mis R, Barbanoj M, Abadias M, Jane F, Forn J. Ramis J, et al. Among authors: mis r. Int J Clin Pharmacol Ther Toxicol. 1988 Sep;26(9):421-7. Int J Clin Pharmacol Ther Toxicol. 1988. PMID: 3264273

5

In-vitro protein binding interaction between a metabolite of triflusal, 2-hydroxy-4-trifluoromethylbenzoic acid and other drugs.

Mis R, Ramis J, Conte L, Forn J. Mis R, et al. J Pharm Pharmacol. 1992 Nov;44(11):935-7. doi: 10.1111/j.2042-7158.1992.tb03241.x. J Pharm Pharmacol. 1992. PMID: 1361542

6

Binding of a metabolite of triflusal (2-hydroxy-4-trifluoromethylbenzoic acid) to serum proteins in rat and man.

Mis R, Ramis J, Conte L, Forn J. Mis R, et al. Eur J Clin Pharmacol. 1992;42(2):175-9. doi: 10.1007/BF00278480. Eur J Clin Pharmacol. 1992. PMID: 1618249

7

Pharmacokinetics of triflusal and its main metabolite in rats and dogs.

Ramis J, Mis R, Forn J. Ramis J, et al. Among authors: mis r. Eur J Drug Metab Pharmacokinet. 1991 Oct-Dec;16(4):261-8. doi: 10.1007/BF03189970. Eur J Drug Metab Pharmacokinet. 1991. PMID: 1823869

8

Pharmacokinetics of triflusal and its main metabolite HTB in healthy subjects following a single oral dose.

Ramis J, Mis R, Forn J, Torrent J, Gorina E, Jané F. Ramis J, et al. Among authors: mis r. Eur J Drug Metab Pharmacokinet. 1991 Oct-Dec;16(4):269-73. doi: 10.1007/BF03189971. Eur J Drug Metab Pharmacokinet. 1991. PMID: 1823870

9

Pharmacokinetics of triflusal after single and repeated doses in man.

Ramis J, Torrent J, Mis R, Conte L, Barbanoj MJ, Jané J, Forn J. Ramis J, et al. Among authors: mis r. Int J Clin Pharmacol Ther Toxicol. 1990 Aug;28(8):344-9. Int J Clin Pharmacol Ther Toxicol. 1990. PMID: 2272716

10

Pharmacokinetics of fosfosal in rats and dogs.

Ramis J, Mis R, Forn J. Ramis J, et al. Among authors: mis r. Arzneimittelforschung. 1989 Jan;39(1):74-7. Arzneimittelforschung. 1989. PMID: 2719746

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters